Table 1.

The molecular identification and enumeration of amino acid triplets among HLA alleles belonging to the same serologic family and cross-reactive groups for patient 15




Position:

9

11

14

16

41

45

56

59

62

66

70

74

76

80

82

90

105

107

127

131

138

142

144

147

149

151

156

158

163

166

171

177

180

183

186

193

199

Trp
Patient   A*0207   F   Sv   R   Gr   A   Me   G   Y   Ge   rKv   aHs   H   Vd   gTI   IRg   A   S   W   K   R   M   mT   tKh   W   aAh   aHv   L   A   T   Ew   Y   Et   Q   A   K   Av   A   —  
Patient   A*2402   S   Sv   R   Gr   A   Me   G   Y   Ee   gKv   aHs   D   En   RIa   aLr   A   S   G   K   R   M   mI   tKr   W   aAh   aHv   Q   A   T   Dg   Y   Et   Q   P   K   Pi   A   —  
Patient   B*0705   Y   Sv   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   R   T   tI   tQr   W   aAr   aRe   R   A   E   Ew   Y   Dk   E   P   K   Pi   A   —  
Patient   B*1502   Y   Am   R   Gr   A   Ma   G   Y   Rn   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   L   Ew   Y   Et   Q   P   K   Pi   A   —  
B7 CREG   B*5501   Y   Am   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   T   Ew   Y   Et   Q   P   K   Pi   A   0  
B7 CREG   B*5601   Y   Am   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   L   Ew   Y   Et   Q   P   K   Pi   A   1  
B7 CREG   B*5401   Y   Am   R   Gr   A   Ge   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   T   Ew   Y   Et   Q   P   K   Pi   A   2  
B7 CREG   B*4002   H   Sv   R   Gr   T   Ke   G   Y   Re   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   R   T   tI   tQr   W   aAr   aRv   L   A   E   Ew   Y   Et   Q   P   K   Pi   A   5  
B7 CREG   B*4001   H   Am   R   Gr   T   Ke   G   Y   Re   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   R   T   tI   sQr   L   aAr   aRv   L   A   E   Ew   Y   Dk   E   P   K   Pi   A   7  
B7 CREG   B*2705   H   Sv   R   Gr   A   Ee   G   Y   Re   qIc   aKa   D   Ed   rTI   ILr   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   E   Ew   Y   Et   Q   P   K   Pi   A   8  
Non Cross Reactive   B*1401   Y   Sb   R   Gr   A   Ee   G   Y   Rn   qIc   tNt   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   T   Ew   H   Et   Q   P   K   Pi   A   2  
Non Cross Reactive
 
B*3801
 
Y
 
Sv
 
R
 
Gr
 
A
 
Ee
 
G
 
Y
 
Rn
 
qIc
 
tNt
 
Y
 
En
 
rla
 
aLr
 
A
 
P
 
G
 
N
 
S
 
T
 
tI
 
tQr
 
W
 
aAr
 
aRv
 
L
 
T
 
T
 
Ew
 
Y
 
Et
 
Q
 
P
 
K
 
Pi
 
A
 
3
 



Position:

9

11

14

16

41

45

56

59

62

66

70

74

76

80

82

90

105

107

127

131

138

142

144

147

149

151

156

158

163

166

171

177

180

183

186

193

199

Trp
Patient   A*0207   F   Sv   R   Gr   A   Me   G   Y   Ge   rKv   aHs   H   Vd   gTI   IRg   A   S   W   K   R   M   mT   tKh   W   aAh   aHv   L   A   T   Ew   Y   Et   Q   A   K   Av   A   —  
Patient   A*2402   S   Sv   R   Gr   A   Me   G   Y   Ee   gKv   aHs   D   En   RIa   aLr   A   S   G   K   R   M   mI   tKr   W   aAh   aHv   Q   A   T   Dg   Y   Et   Q   P   K   Pi   A   —  
Patient   B*0705   Y   Sv   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   R   T   tI   tQr   W   aAr   aRe   R   A   E   Ew   Y   Dk   E   P   K   Pi   A   —  
Patient   B*1502   Y   Am   R   Gr   A   Ma   G   Y   Rn   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   L   Ew   Y   Et   Q   P   K   Pi   A   —  
B7 CREG   B*5501   Y   Am   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   T   Ew   Y   Et   Q   P   K   Pi   A   0  
B7 CREG   B*5601   Y   Am   R   Gr   A   Ee   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   L   Ew   Y   Et   Q   P   K   Pi   A   1  
B7 CREG   B*5401   Y   Am   R   Gr   A   Ge   G   Y   Rn   qIy   aQa   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   T   Ew   Y   Et   Q   P   K   Pi   A   2  
B7 CREG   B*4002   H   Sv   R   Gr   T   Ke   G   Y   Re   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   R   T   tI   tQr   W   aAr   aRv   L   A   E   Ew   Y   Et   Q   P   K   Pi   A   5  
B7 CREG   B*4001   H   Am   R   Gr   T   Ke   G   Y   Re   qIs   tNt   Y   Es   rNI   IRg   A   P   G   N   R   T   tI   sQr   L   aAr   aRv   L   A   E   Ew   Y   Dk   E   P   K   Pi   A   7  
B7 CREG   B*2705   H   Sv   R   Gr   A   Ee   G   Y   Re   qIc   aKa   D   Ed   rTI   ILr   A   P   G   N   S   T   tI   tQr   W   aAr   aRv   L   A   E   Ew   Y   Et   Q   P   K   Pi   A   8  
Non Cross Reactive   B*1401   Y   Sb   R   Gr   A   Ee   G   Y   Rn   qIc   tNt   D   Es   rNI   IRg   A   P   G   N   S   T   tI   tQr   W   aAr   aRe   L   A   T   Ew   H   Et   Q   P   K   Pi   A   2  
Non Cross Reactive
 
B*3801
 
Y
 
Sv
 
R
 
Gr
 
A
 
Ee
 
G
 
Y
 
Rn
 
qIc
 
tNt
 
Y
 
En
 
rla
 
aLr
 
A
 
P
 
G
 
N
 
S
 
T
 
tI
 
tQr
 
W
 
aAr
 
aRv
 
L
 
T
 
T
 
Ew
 
Y
 
Et
 
Q
 
P
 
K
 
Pi
 
A
 
3
 

The molecular identification and enumeration of amino acid triplets among HLA alleles belonging to the same serological family and cross-reactive groups for patient 15: the HLA matching algorithm is based on comparisons of linear sequences of amino acid triplets in antibody-accessible positions as motifs for potentially immunogenic epitopes. Each HLA antigen represents a distinct string of polymorphic triplets. The self-triplet repertoire for patient 15, with the HLA-A*0207, A*2402; B*0705/6, B*1502 phenotype is shown. Using HLA-B*0705 (serologically HLA-B7) as an example, this table also shows how representative antigens of the B7 CREG are matched at the structural level. While the HLA-B22 splits B*5501, B*5601, and B*5401 are well-matched, other B7-crossreactive antigens like B*4001, B*4002, and B*2705 have many mismatched triplets (see text for details). Last column: Trp indicates total number of triplet mismatches between HLA-B*0705 and each allele analyzed. The positions on top of the table represent polymorphic sites of HLA molecules accessible to antibodies. Each triplet is designated by its amino acid composition around a given position in the amino acid sequence. Amino acid residues are marked with the standard letter code; an uppercase corresponds to the residue in the numbered position, whereas the lowercase letters describe the nearest neighboring residues. For instance, the triplet 151 aRv represents an arginine (R) in position 151 with an alanine (a) in position 150 and a valine (v) in position 152. Many triplets are marked with one or two residues only, because their neighboring residues are the same on all HLA class I chains and they are, therefore, not shown.

or Create an Account

Close Modal
Close Modal